Request Trial
shutterstock_1532109092_sundry_photography
Sundry Photography / Shutterstock.com
7 October 2021MedTech

Federal Circuit hands victory to Snyders over heart valve patent

The US Court of Appeals for the Federal Circuit has held that claims of a patent covering an artificial heart valve were erroneously held to be unpatentable by the US Patent Trial and Appeal Board (PTAB), in a blow to a medical device company owned by Abbott Laboratories.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

MedTech
Abbott clinches 18-country PI in glucose monitoring feud
9 September 2026   The UPC has handed the medical device company a significant win over continuous glucose monitoring tech, granting a broad provisional injunction after finding that SiBio’s rival system was likely to infringe its European patent.
MedTech
Sun Pharma import ban back in force after Squires intervention
3 September 2026   A decision at the USPTO has cleared the way for renewed enforcement in the drugmaker’s dispute over light-based dermatology tech.
MedTech
Abbott fends off Chinese rival’s patent challenge at UPC
18 August 2026   The European court has backed Abbott in a dispute over glucose-monitoring technology, while offering guidance on a key added-matter issue.


Editor's picks

Inside the deal boom: LSIPR’s five-part M&A series—all in one place
Regulation & Industry
Inside the deal boom: LSIPR’s five-part M&A series—all in one place
17 September 2026

Editor's picks

Regulation & Industry
Inside the deal boom: LSIPR’s five-part M&A series—all in one place
17 September 2026

More features

Leading European patent litigator to join Carpmaels & Ransford
CIPA Congress: Sustainability is essential for the profession and the planet
Non-profit sues Cambrex over anticancer drug manufacturing trade secrets
Inside the deal boom: LSIPR’s five-part M&A series—all in one place
Amgen hit with lawsuit over its proposed Opdivo biosimilar
Australian biotech sues Grail over multi-cancer blood test
K&L Gates hires six-strong team of IP and corporate lawyers from Pillsbury
Perfect Pitch: Inside the scheme that gets junior lawyers selling to clients